NRIX $0.00 ( 0.00%) Quote details

stock

Nurix Therapeutics Inc

NASDAQ | NRIX

11.47

USD

0.00 ( 0.00%)

AT CLOSE (AS OF Apr 28, 2025)

$881M

MARKET CAP

-

P/E Ratio

-2.79

EPS

$30

52 Week High

$8.2

52 Week Low

LIFE SCIENCES

Sector

NRIX Chart

1D
Area

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

NRIX Technicals

Tags:

NRIX Earnings

Yearly Income Statement (As of Nov 30, 2024)

Field Value (USD)
Gross Profit $55M
Total Revenue $55M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$213M
Selling General And Administrative $46M
Research And Development $222M
Operating Expenses $268M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$193M
Income Tax Expense $270K
Interest And Debt Expense -
Net Income From Continuing Operations -$194M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda -$213M
Net Income -$194M

Revenue & Profitability

Earnings Performance

NRIX Financials

yearly Balance Sheet (As of Nov 30, 2024)

Field Value (USD)
Total Assets $669M
Total Current Assets $619M
Cash And Cash Equivalents At Carrying Value $110M
Cash And Short Term Investments $110M
Inventory -
Current Net Receivables -
Total Non Current Assets $50M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $500M
Other Current Assets $9.8M
Other Non Current Assets -
Total Liabilities $142M
Total Current Liabilities $96M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $8M
Total Non Current Liabilities $46M
Capital Lease Obligations $28M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $28M
Other Current Liabilities $37M
Other Non Current Liabilities -
Total Shareholder Equity $527M
Treasury Stock -
Retained Earnings -$739M
Common Stock $76K
Common Stock Shares Outstanding $67M

yearly Cash Flow (As of Nov 30, 2024)

Field Value (USD)
Operating Cashflow -$173M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$2M
Capital Expenditures $9.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $486M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$194M

yearly Income Statement (As of Nov 30, 2024)

Field Value (USD)
Gross Profit $55M
Total Revenue $55M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$213M
Selling General And Administrative $46M
Research And Development $222M
Operating Expenses $268M
Investment Income Net -
Net Interest Income $20M
Interest Income $20M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$193M
Income Tax Expense $270K
Interest And Debt Expense -
Net Income From Continuing Operations -$194M
Comprehensive Income Net Of Tax -
Ebit -
Ebitda -$213M
Net Income -$194M

NRIX News

NRIX Profile

Nurix Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company is headquartered in San Francisco, California.

AGMH
175.72%
$0.134
LGMK
48.28%
$0.0129
DMN
8.57%
$0.0038
DGLY
12.10%
$0.0315
PTPI
7.22%
$0.0579
GNLN
-3.23%
$0.012
PLUG
25.68%
$1.02
NVDA
-2.05%
$108.73
TSLA
0.33%
$285.88
WW
4.52%
$0.4135
OMEX
-12.58%
$1.32
PLTR
1.66%
$114.65
INTC
2.29%
$20.51
SOFI
2.48%
$13.2
F
-0.20%
$10.02
LCID
1.20%
$2.53
PONY
47.22%
$10.32
AZUL
6.01%
$0.88
DNN
5.04%
$1.46
GLMD
6.37%
$1.67
BON
13.24%
$0.065
NIO
6.82%
$4.305
AAL
1.03%
$9.85
PFE
0.57%
$23.05
LYT
-16.78%
$0.0982
SNAP
3.40%
$8.83
WULF
0.67%
$3.02
BTG
0.32%
$3.09
GRAB
-0.42%
$4.76
AVTR
-16.58%
$12.93
SMCI
2.19%
$37.27
AAPL
0.41%
$210.14
WBD
1.28%
$8.7
BAC
0.23%
$39.78
HOOD
-1.05%
$48.93
RIVN
4.52%
$13.19
JBLU
4.90%
$4.07
AMZN
-0.68%
$187.7
HIMS
1.46%
$28.5
AMCR
0.94%
$9.63
ABEV
1.01%
$2.495
RGTI
-1.60%
$9.22
AMD
-0.26%
$96.39
RIG
-0.86%
$2.31
RIOT
-1.80%
$7.63
AGNC
1.92%
$9.02
MARA
-2.03%
$14.01
QBTS
-2.12%
$7.37
ME
-21.26%
$0.6063
GOOGL
-0.83%
$160.61
APLD
0.21%
$4.71
CUTR
-10.19%
$0.0969
ERIC
0.61%
$8.24
FFAI
24.76%
$1.31
MLGO
-10.23%
$7.11
PMAX
7.30%
$0.4216
T
1.68%
$27.26
SAG
42.57%
$1.44
CLSK
-4.88%
$8.57
VALE
1.21%
$9.615
ITUB
1.06%
$6.205
ONCO
14.45%
$0.08
NAAS
-20.50%
$1.45
BTE
0.00%
$1.65
BBD
0.42%
$2.39
GOOG
-0.87%
$162.42
KGC
1.97%
$14.775
SOUN
2.31%
$9.74
MU
3.05%
$79.78
GNPX
2.88%
$0.293
FNA
0.00%
$13.09
IQ
-1.56%
$1.89
KHC
-2.31%
$28.81
NGD
-0.29%
$3.38
VRN
1.22%
$6.205
AG
0.97%
$6.25
BMY
1.16%
$48.455
GWAV
12.13%
$0.196
CMG
-1.70%
$50.9
TGB
3.73%
$2.365
CCL
1.42%
$18.865
HL
0.43%
$5.875
HTZ
-4.05%
$8.3
NOK
-1.50%
$4.915
WFC
-0.42%
$69.435
MSFT
-0.18%
$391.16
CSCO
0.75%
$56.71
AVGO
0.08%
$192.47
ACHR
-0.70%
$8.53
BTOG
4.10%
$0.16
AEG
1.16%
$6.525
BITF
-0.97%
$1.02
VZ
1.15%
$42.39
KO
-0.17%
$71.79
AUR
5.52%
$7.26
PBR
0.26%
$11.51
RLMD
-44.64%
$0.3571
HBAN
1.25%
$14.58
HPE
1.54%
$16.49
TLRY
-2.09%
$0.4769
AGMH
175.72%
$0.134
LGMK
48.28%
$0.0129
DMN
8.57%
$0.0038
DGLY
12.10%
$0.0315
PTPI
7.22%
$0.0579
GNLN
-3.23%
$0.012
PLUG
25.68%
$1.02
NVDA
-2.05%
$108.73
TSLA
0.33%
$285.88
WW
4.52%
$0.4135
OMEX
-12.58%
$1.32
PLTR
1.66%
$114.65
INTC
2.29%
$20.51
SOFI
2.48%
$13.2
F
-0.20%
$10.02
LCID
1.20%
$2.53
PONY
47.22%
$10.32
AZUL
6.01%
$0.88
DNN
5.04%
$1.46
GLMD
6.37%
$1.67
BON
13.24%
$0.065
NIO
6.82%
$4.305
AAL
1.03%
$9.85
PFE
0.57%
$23.05
LYT
-16.78%
$0.0982
SNAP
3.40%
$8.83
WULF
0.67%
$3.02
BTG
0.32%
$3.09
GRAB
-0.42%
$4.76
AVTR
-16.58%
$12.93
SMCI
2.19%
$37.27
AAPL
0.41%
$210.14
WBD
1.28%
$8.7
BAC
0.23%
$39.78
HOOD
-1.05%
$48.93
RIVN
4.52%
$13.19
JBLU
4.90%
$4.07
AMZN
-0.68%
$187.7
HIMS
1.46%
$28.5
AMCR
0.94%
$9.63
ABEV
1.01%
$2.495
RGTI
-1.60%
$9.22
AMD
-0.26%
$96.39
RIG
-0.86%
$2.31
RIOT
-1.80%
$7.63
AGNC
1.92%
$9.02
MARA
-2.03%
$14.01
QBTS
-2.12%
$7.37
ME
-21.26%
$0.6063
GOOGL
-0.83%
$160.61
APLD
0.21%
$4.71
CUTR
-10.19%
$0.0969
ERIC
0.61%
$8.24
FFAI
24.76%
$1.31
MLGO
-10.23%
$7.11
PMAX
7.30%
$0.4216
T
1.68%
$27.26
SAG
42.57%
$1.44
CLSK
-4.88%
$8.57
VALE
1.21%
$9.615
ITUB
1.06%
$6.205
ONCO
14.45%
$0.08
NAAS
-20.50%
$1.45
BTE
0.00%
$1.65
BBD
0.42%
$2.39
GOOG
-0.87%
$162.42
KGC
1.97%
$14.775
SOUN
2.31%
$9.74
MU
3.05%
$79.78
GNPX
2.88%
$0.293
FNA
0.00%
$13.09
IQ
-1.56%
$1.89
KHC
-2.31%
$28.81
NGD
-0.29%
$3.38
VRN
1.22%
$6.205
AG
0.97%
$6.25
BMY
1.16%
$48.455
GWAV
12.13%
$0.196
CMG
-1.70%
$50.9
TGB
3.73%
$2.365
CCL
1.42%
$18.865
HL
0.43%
$5.875
HTZ
-4.05%
$8.3
NOK
-1.50%
$4.915
WFC
-0.42%
$69.435
MSFT
-0.18%
$391.16
CSCO
0.75%
$56.71
AVGO
0.08%
$192.47
ACHR
-0.70%
$8.53
BTOG
4.10%
$0.16
AEG
1.16%
$6.525
BITF
-0.97%
$1.02
VZ
1.15%
$42.39
KO
-0.17%
$71.79
AUR
5.52%
$7.26
PBR
0.26%
$11.51
RLMD
-44.64%
$0.3571
HBAN
1.25%
$14.58
HPE
1.54%
$16.49
TLRY
-2.09%
$0.4769
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.